Lates News

Cardiff Oncology (CRDF.US): The financial report for Q1 2025 shows a revenue of $109,000, down from $205,000 in the previous period, but better than the expected $75,000. The earnings per share were -$0.20, slightly better than the previous -$0.22 and on par with the expected -$0.20.